PLX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

PLXProtalix BioTherapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

PLXProtalix BioTherapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PLX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.4%▲+7.82%×0.63

May 13 '26±17.0%▲+1.05%×0.06

Q1 FY26±15.2%▼−20.79%×1.37

Q3 FY25±28.3%▼−9.81%×0.35

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

= impliedPLX realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 29%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

PLXProtalix BioTherapeutics, Inc.

2.52▼−6.51%· post 2.52

Mkt cap$216.7MRevenue$20MQ2 FY26Revenue$53MFY25

AMGNAmgen Inc

461.49▼−3.55%· post 460.22

ClosedNov 5 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 5 '26

PLXProtalix BioTherapeutics, Inc.

AMGNAmgen Inc

2.52▼−6.51%post 2.52

Price

461.49▼−3.55%post 460.22

$216.7M

Mkt cap

$249.0B

Q2 FY26$20M

Revenue

$10.4BQ3 FY26

FY25$53M

Revenue

$36.8BFY25

PLX2.52▼−6.51%vsAMGN461.49▼−3.55%ClosedNov 5 '26